Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBX-2044 in Patients With Type 2 Diabetes
NCT00422487Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MBX-2044 in type 2 diabetes mellitus (T2DM), sponsored by Gilead Sciences. Started Oct 2006; status: completed.
02
Drugs
MBX-2044
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00422487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422487.